EARNING RECAP

Illumina Inc

#ILMN 2019 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q1 adjusted $1.60 est. $1.34 $846M e st. $834.36M -1.62% ($314.04 closing price) $315.80 $305.18 raises Fy19 EPS view to $6.63-$6.73 from $6.50-$6.60; est. $6.53 backs FY19 revenue view up 13%- 14% est. $3.78B
#ILMN 2018 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 $1.32 est. $1.36 $867M est. $863.54M -4.45% ($272.57 closing price) $281.75 $268.62 backs Fy19 adjusted EPS view $6.50- $6.60 est. $6.46; FY19 revenue growth `13%- 14%
Q3 $1.52 est. $1.26 $853M est. $828.59M -7.74% ($289.50 closing price) $320.03 $288.92 sees FY18 adjusted EPS $5.70- $5.75 est. $5.45; sees FY18 revenue growth roughly 20% est. $3.31B
Q2 $1.43 vs $1.11 $830M vs $785.56M +12.14% $325.22 $304.16 raises FY18 EPS view to $5.35-$5.45 from $4.75-$4.85, consensus $4.87
Q1 adjusted $1.45 est. $1.02 $782M est. $743.54M -3.06% ($231.19 closing) $251.99 $226.62 raises FY8 $4.75-$4.85M from $4.50-$4.60 est. $4.59, raises revenue growth 15%-16% from 13%-14%
#ILMN 2017 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 $1.44 est. $1.22 $778M est. $750.24 -3.54% ( $232.64 closing price) $248.10 $229.16 FY18 adjusted EPS view $4.50-$4.60 est $4.58; sees FY18 revenue $3.13B
Q3 $1.11 vs 99c $714m Vs $692.8M -2.83% 214.03 198.21 *sell thegap reaction, from 52 weekshigh to red* Sees FY17 EPS $3.373-$3.78, vs $3.65
Q2 $1.51 vs 39c $662M vs 642.36M +14.83% or +25.55 points. Closed at $197.85 $198.47 $188.00 FY17 Projections to approximately 12% revenue growth.
Q1 64c vs 64c $598.00m Vs $590.75M +1.70% closed at $184.58 $184.96 $177.32 sees Q2 adjusted EPS 65c-70c, consensus 87c.

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that TradersFish.com will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.